252 related articles for article (PubMed ID: 10761543)
1. [Diagnostic significance of antinuclear antibodies].
Swaak AJ
Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic significance of antinuclear antibodies].
Glass AS; Bossuyt PM
Ned Tijdschr Geneeskd; 2000 May; 144(22):1087. PubMed ID: 10850116
[No Abstract] [Full Text] [Related]
3. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of antinuclear antibody tests in children.
McGhee JL; Kickingbird LM; Jarvis JN
BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
[TBL] [Abstract][Full Text] [Related]
5. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
6. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
7. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies].
Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N
Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906
[TBL] [Abstract][Full Text] [Related]
9. Measurement of serum antinuclear antibody titer in dogs with and without systemic lupus erythematosus: 120 cases (1997-2005).
Smee NM; Harkin KR; Wilkerson MJ
J Am Vet Med Assoc; 2007 Apr; 230(8):1180-3. PubMed ID: 17501657
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up.
Al-Allaf AW; Ottewell L; Pullar T
Clin Rheumatol; 2002 Nov; 21(6):472-7. PubMed ID: 12447630
[TBL] [Abstract][Full Text] [Related]
11. The clinical utility of a positive antinuclear antibody test result.
Abeles AM; Abeles M
Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and significance of antinuclear antibodies].
Federmann M
Dtsch Med Wochenschr; 1994 Aug; 119(33):1137-8. PubMed ID: 8070339
[No Abstract] [Full Text] [Related]
13. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
[TBL] [Abstract][Full Text] [Related]
14. [Theoretical objective evaluation of the value of a diagnostic criterion. Application to antinuclear antibodies for the diagnosis of systemic lupus erythematosus].
Vinceneux P; Yeni P; Boboc B; Carbon C
Rev Rhum Mal Osteoartic; 1984 Oct; 51(9):493-6. PubMed ID: 6334353
[TBL] [Abstract][Full Text] [Related]
15. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
[TBL] [Abstract][Full Text] [Related]
16. The development of connective tissue diseases in patients with autoimmune hepatitis: a case series.
West M; Jasin HE; Medhekar S
Semin Arthritis Rheum; 2006 Jun; 35(6):344-8. PubMed ID: 16765710
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.
Divate S; Hardikar P; Bichile LS; Rajadhyaksha A
J Assoc Physicians India; 2004 Apr; 52():290-3. PubMed ID: 15636329
[TBL] [Abstract][Full Text] [Related]
18. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibodies heralding the onset of systemic lupus erythematosus.
Aho K; Koskela P; Mäkitalo R; Heliövaara M; Palosuo T
J Rheumatol; 1992 Sep; 19(9):1377-9. PubMed ID: 1433004
[TBL] [Abstract][Full Text] [Related]
20. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
Clegg DO; Williams HJ; Singer JZ; Steen VD; Schlegel S; Ziminski C; Alarcón GS; Luggen ME; Polisson RP; Willkens RF
J Rheumatol; 1991 Sep; 18(9):1340-3. PubMed ID: 1757935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
